Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycation: a pathological modification in neuropathies?: a hypothesis

C A Colaco1, C R Harrington

  • 1Quadrant Research Foundation, Cambridge, UK.

Neuroreport
|April 14, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Continued Impact of Acute Rejection in the Last Decade of Liver Transplantation.

Gastro hep advances·2022
Same author

Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration.

Cellular and molecular life sciences : CMLS·2014
Same author

Addictive-like behaviours to ultraviolet light among frequent indoor tanners.

Clinical and experimental dermatology·2010
Same author

Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics.

Neuroscience letters·2002
Same author

Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.

Journal of chemical neuroanatomy·2001
Same author

Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

The American journal of pathology·2000

Protein glycation may explain how normal proteins form amyloid plaques in neuropathies. This research explores how these modifications contribute to neural amyloid formation and disease.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Neuropathies often feature neural amyloid lesions.
  • Key components of these lesions are known, but the modification process is unclear.

Purpose of the Study:

  • To propose that protein glycation is the modification process leading to amyloid formation in neuropathies.
  • To link protein glycation to neuropathogenesis.

Main Methods:

  • Literature review and hypothesis formulation.
  • Analysis of existing data on amyloid formation and protein modification.

Main Results:

  • Hypothesis presented: protein glycation modifies normal cellular proteins.
  • Glycation is proposed as a key step in amyloidogenesis within neuropathies.

Related Experiment Videos

Conclusions:

  • Protein glycation is a plausible mechanism driving amyloid formation in neuropathies.
  • Further research is needed to validate the role of glycation in neuropathogenesis.